The human membrane-bound enzyme CD39 may be able to improve the survival of sepsis, according to a study published in The Journal of the Federation of American Societies for Experimental Biology.

Targeting an enzyme called cGAS could be a promising pathway for developing much-needed new immunity-based therapies aimed at treating tuberculosis infection, according to a new study from the ...